Page last updated: 2024-08-25

frovatriptan and Hypomenorrhea

frovatriptan has been researched along with Hypomenorrhea in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (66.67)	29.6817
2010's	4 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allais, G; Barbanti, P; Benedetto, C; Bussone, G; Cortelli, P; Curone, M; D'Onofrio, F; Sette, G; Tullo, V; Valguarnera, F	1
Airola, G; Allais, G; Benedetto, C; Borgogno, P; Bussone, G; De Lorenzo, C; Gabellari, IC; Pavia, E	1
Campbell, J; Harper, S; Jones, BA; Newman, LC	1
Berner, T; Campbell, JC; Silberstein, SD; Tobin, J; Xiang, Q	1
Brandes, JL; Czapinski, P; Jeka, S; MacGregor, EA; Pawsey, S; Shaw, B; Silberstein, S	1
Campbell, JC; Hu, X; MacGregor, EA; Pawsey, SP	1
Ferrari, MD; Lisotto, C; Omboni, S; Pinessi, L; Savi, L; Zanchin, G; Zava, D	1
Bartolini, M; Brighina, F; Ferrari, MD; Fierro, B; Giamberardino, MA; Lisotto, C; Martelletti, P; Moscato, D; Omboni, S; Panascia, B; Pini, LA; Sances, G; Santoro, P; Savi, L; Zanchin, G	1
Balbisi, EA	1
Adelman, JU; Calhoun, A	1
Barrilà, C; Belloni, C; Guidotti, F; Guidotti, M; Mauri, M	1
Elkind, AH; MacGregor, EA	1

Reviews

3 review(s) available for frovatriptan and Hypomenorrhea

Article	Year
Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies. Gender medicine, 2010, Volume: 7, Issue:2 Topics: Acute Disease; Carbazoles; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Safety; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2010
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. International journal of clinical practice, 2004, Volume: 58, Issue:7 Topics: Carbazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2004
Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine. Expert review of neurotherapeutics, 2008, Volume: 8, Issue:5 Topics: Carbazoles; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2008

Trials

7 trial(s) available for frovatriptan and Hypomenorrhea

Article	Year
Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial. Cephalalgia : an international journal of headache, 2015, Volume: 35, Issue:1 Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Menstruation Disturbances; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines	2015
Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2008, Volume: 29 Suppl 1 Topics: Adult; Carbazoles; Contraceptives, Oral; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Pain Measurement; Pilot Projects; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Tryptamines	2008
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation. Headache, 2009, Volume: 49, Issue:9 Topics: Acute Disease; Adult; Carbazoles; Cross-Over Studies; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Nausea; Pain Measurement; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Tryptamines	2009
Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache, 2009, Volume: 49, Issue:9 Topics: Adult; Carbazoles; Chest Pain; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Menstruation Disturbances; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2009
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. The journal of headache and pain, 2011, Volume: 12, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult	2011
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study. The journal of headache and pain, 2012, Volume: 13, Issue:5 Topics: Adult; Carbazoles; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Proportional Hazards Models; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Tryptamines	2012
Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine. The journal of headache and pain, 2007, Volume: 8, Issue:5 Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Estrogens; Female; Humans; Menstruation Disturbances; Migraine Disorders; Naproxen; Pain Measurement; Pilot Projects; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2007

Other Studies

2 other study(ies) available for frovatriptan and Hypomenorrhea

Article	Year
Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study. Journal of women's health (2002), 2009, Volume: 18, Issue:8 Topics: Adult; Carbazoles; Drug Administration Schedule; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Product Surveillance, Postmarketing; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Women's Health; Young Adult	2009
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology, 2005, Mar-08, Volume: 64, Issue:5 Topics: Adult; Carbazoles; Cost-Benefit Analysis; Female; Gonadal Steroid Hormones; Humans; Menstruation Disturbances; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents	2005

Article

Year

Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.

Journal of women's health (2002), 2009, Volume: 18, Issue:8

Topics: Adult; Carbazoles; Drug Administration Schedule; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Product Surveillance, Postmarketing; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Women's Health; Young Adult

2009

A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.

Neurology, 2005, Mar-08, Volume: 64, Issue:5

Topics: Adult; Carbazoles; Cost-Benefit Analysis; Female; Gonadal Steroid Hormones; Humans; Menstruation Disturbances; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents

2005